Cigna Investments Inc. New Purchases New Position in Walgreens Boots Alliance Inc (WBA)

Cigna Investments Inc. New purchased a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 31,617 shares of the pharmacy operator’s stock, valued at approximately $2,617,000.

A number of other large investors have also modified their holdings of the company. Cobiz Investment Management LLC raised its position in shares of Walgreens Boots Alliance by 0.3% in the third quarter. Cobiz Investment Management LLC now owns 7,423 shares of the pharmacy operator’s stock worth $598,000 after buying an additional 25 shares during the last quarter. Naples Global Advisors LLC raised its position in shares of Walgreens Boots Alliance by 1.8% in the third quarter. Naples Global Advisors LLC now owns 9,718 shares of the pharmacy operator’s stock worth $784,000 after buying an additional 176 shares during the last quarter. Fisher Asset Management LLC raised its position in shares of Walgreens Boots Alliance by 4.3% in the third quarter. Fisher Asset Management LLC now owns 6,726 shares of the pharmacy operator’s stock worth $542,000 after buying an additional 277 shares during the last quarter. Jacobs & Co. CA raised its position in shares of Walgreens Boots Alliance by 2.8% in the third quarter. Jacobs & Co. CA now owns 98,845 shares of the pharmacy operator’s stock worth $7,968,000 after buying an additional 2,674 shares during the last quarter. Finally, First Financial Bank N.A. Trust Division raised its position in shares of Walgreens Boots Alliance by 5.7% in the third quarter. First Financial Bank N.A. Trust Division now owns 2,908 shares of the pharmacy operator’s stock worth $234,000 after buying an additional 158 shares during the last quarter. Institutional investors and hedge funds own 59.98% of the company’s stock.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at 82.97 on Friday. The firm has a 50-day moving average of $84.75 and a 200 day moving average of $83.04. Walgreens Boots Alliance Inc has a 52 week low of $75.74 and a 52 week high of $88.00. The company has a market cap of $89.56 billion, a P/E ratio of 21.96 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.01. The business earned $28.50 billion during the quarter. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The firm’s revenue for the quarter was down 1.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.03 EPS. Equities analysts expect that Walgreens Boots Alliance Inc will post $5.00 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Wednesday, February 15th were paid a dividend of $0.375 per share. The ex-dividend date was Monday, February 13th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.81%. Walgreens Boots Alliance’s dividend payout ratio is currently 39.68%.

WARNING: This news story was originally published by Web Breaking News and is owned by of Web Breaking News. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at http://www.webbreakingnews.com/2017/03/26/cigna-investments-inc-new-purchases-new-position-in-walgreens-boots-alliance-inc-wba.html.

A number of research analysts have recently weighed in on the company. Jefferies Group LLC restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, December 21st. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, March 8th. Leerink Swann set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, January 8th. Deutsche Bank AG restated a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a research report on Friday, January 6th. Finally, Evercore ISI restated a “buy” rating and set a $93.00 price objective on shares of Walgreens Boots Alliance in a research report on Tuesday, January 31st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $91.48.

In related news, COO Ornella Barra bought 124,000 shares of the business’s stock in a transaction dated Tuesday, February 7th. The stock was acquired at an average price of $80.93 per share, with a total value of $10,035,320.00. Following the completion of the purchase, the chief operating officer now directly owns 1,690,336 shares of the company’s stock, valued at $136,798,892.48. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Janice M. Babiak bought 600 shares of the business’s stock in a transaction dated Thursday, February 2nd. The shares were bought at an average cost of $80.68 per share, with a total value of $48,408.00. Following the purchase, the director now directly owns 600 shares of the company’s stock, valued at $48,408. The disclosure for this purchase can be found here. 13.50% of the stock is owned by insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.